Technology Primer · Mass Spectrometry Imaging

Immunohistochemistry (IHC) and Mass Spectrometry Imaging

Immunohistochemistry (IHC) uses antigen-antibody reactions to chromogenically label the spatial distribution of specific proteins. It complements the label-free molecular map of mass spectrometry imaging: mass spectrometry discovers which molecules are enriched where, and IHC uses targeted antibodies to cross-validate the localization of specific proteins; after registration, the two form a complementary evidence chain.
Table of Contents
Capability Boundaries of IHCCollaborative Workflow with Mass Spectrometry ImagingRole as a Verification LayerRelationship with H&E and the Overall Annotation System
Schematic principle: ion source ionizes the sample spot-by-spot Tissue section Sample Ionization beam Immunohistochemistry (IHC) and Mass Spectrometry Imaging Ions MS analyzer
Immunohistochemistry (IHC) and Mass Spectrometry Imaging — schematic diagram

Capability Boundaries of IHC

IHC relies on specific antibodies, usually labeling one or a few proteins in a single experiment, providing high-specificity spatial localization; but it is limited by antibody availability and cross-reactivity, and requires labeling sample preparation (fixation, permeabilization, incubation), which may disturb molecular distribution.

In contrast, mass spectrometry imaging is label-free and can observe hundreds to thousands of molecules simultaneously, but its single-molecule specificity is weaker than antibodies. The two complement each other: mass spectrometry for broad discovery, IHC for targeted confirmation.

Collaborative Workflow with Mass Spectrometry Imaging

A common practice is to perform mass spectrometry imaging and IHC on adjacent/serial sections respectively, then align via morphological registration; or do mass spectrometry first and then stain on the same/adjacent section. The key is to ensure section standardization and coordinate sharing so that the ion image and IHC image can be overlaid and interpreted.

For matrix-free ambient sources (LDPI, DPI, DESI), the short chain of imaging first then staining after sectioning is less disturbing; for MALDI, avoid cross-contamination between matrix and staining.

Role as a Verification Layer

When mass spectrometry discovers that a molecule is enriched in a specific region, IHC can verify with an independent principle (antigen-antibody) that the protein is indeed located there, enhancing conclusion credibility, especially valuable for biomarker exploration and clinical connection.

Conversely, targets discovered by IHC can also point back to mass spectrometry for unbiased verification or quantitative-trend confirmation, forming bidirectional evidence. It is recommended to reserve an IHC verification step in the study design.

Relationship with H&E and the Overall Annotation System

H&E provides general morphological partitioning, IHC provides specific protein localization, and mass spectrometry provides unbiased molecular maps; the three form a multi-layer annotation system. After registration, they can be overlaid and interpreted in SCiLS Lab and MetaboScape to support regional-difference analysis.

Writing serial sectioning + standard registration into the SOP ensures comparability and reproducibility of the molecular, morphological, and targeted three-layer annotation.

Frequently Asked Questions (FAQ)

What is the relationship between IHC and mass spectrometry imaging?
Complementary: mass spectrometry is label-free and broadly discovers molecular distribution, while IHC uses antibodies for targeted confirmation of specific protein localization; after registration, the two form a bidirectional evidence chain.
Can IHC replace mass spectrometry imaging?
No. IHC usually labels a few proteins per experiment, is limited by antibodies, and requires labeling sample preparation; mass spectrometry can observe thousands of molecules simultaneously. The two have different discovery and verification roles.
How to align IHC with the ion image?
Use adjacent/serial sections for mass spectrometry and IHC respectively, then register via shared coordinates; the key is section standardization and coordinate sharing so that the two layers of images can be overlaid.
What should be noted for IHC verification with matrix-free sources?
The short chain of imaging first then staining after sectioning is less disturbing; avoid cross-contamination between matrix (if MALDI is used) and staining, and ensure registration accuracy.

Get Specifications & Quotation

To obtain detailed specifications, compatible models, or a quotation for the MSI LDPI / DPI full series imaging ion sources, visit the Neo-Source official website, or contact the official team for compatibility advice tailored to your mass spectrometer (Agilent / SCIEX / Thermo and other mainstream MS).

Related Articles

H&E Staining (Mass Spectrometry Imaging Registration)Tissue Sectioning (Mass Spectrometry Imaging Sample Preparation)Frozen Sectioning (Mass Spectrometry Imaging)MALDISCiLS Lab Mass Spectrometry Imaging Analysis Software

← Back to MSI Ion Source Knowledge Hub